GET PrEP informative campaign

It’s gonna be

PrEP!



GET PrEP informative campaign
It’s gonna be PrEP!


















What is PrEP?

Truvada (the commercial name for emtricitabine/tenofovir) was the first HIV prevention drug. It contains the same components as the therapy that people living with HIV receive. In prophylactic use, the drug prevents the virus entering the body from multiplying, thereby preventing infection.

Our immune system is a large and well-established mechanism, an important part of which are cells called T-lymphocytes. They provide protection to our body against viruses and bacteria. When HIV enters the body, it attacks these T-lymphocytes and begins to multiply within them. This leads to HIV infection.

PrEP (pre-exposure prophylaxis) is a new revolutionary approach to HIV prevention, which prevents the virus from multiplying, so that those viruses penetrating our bodies die quickly. Numerous studies show that the proper use of PrEP reduces the risk to contract HIV via sex almost to zero.

In order to receive maximum protection, HIV-negative people should take one Truvada tablet or its equivalent (drugs from other manufacturers with the same active ingredients) once a day.

In 2015, emtricitabine/tenofovir was approved by the World Health Organization as pre-exposure prophylaxis for HIV and was recommended to people engaged in risky behavior with respect to HIV infection. Presently, PrEP is primarily used by gays and other men who have sex with men.

PrEP protects against HIV infection, an infection that is currently incurable. However, PrEP cannot protect against syphilis and other STIs. Therefore, it is important to remember that PrEP is not an alternative to condoms and other forms of sexual health protection.













It’s simple!



Supported by Eurasian Coalition on Male Health www.ecom.ngo
Copyright © 2019